Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Clinical Medicine|June 12, 2026
Greater Reductions in Hepatitis B Core-Related Antigen Associated with Switching from Entecavir to Tenofovir Alafenamide Compared with Continued Entecavir Therapy: A Retrospective Observational StudyMasanori Fukushima, Satoshi Miuma, Yasuhiko Nakao, et al.
Internal Medicine (Tokyo, Japan)|February 23, 2026
A case of immune-mediated myocarditis after durvalumab/tremelimumab treatment for unresectable hepatocellular carcinomaShogo Mawatari, Ryu Sasaki, Yasuhiko Nakao, et al.
Internal Medicine (Tokyo, Japan)|April 8, 2026
A Phase Angle Used as a Screening Tool for Malnutrition in Japanese Patients with Liver CirrhosisMasafumi Haraguchi, Satoshi Miuma, Yasuhiko Nakao, et al.
Scientific Reports|August 23, 2023
Hypoglycemia measured by flash glucose monitoring system predicts liver-related events in chronic liver disease patientsRyu Sasaki, Naota Taura, Yasuhiko Nakao, et al.
Scientific Reports|March 20, 2024
Investigation of deep learning model for predicting immune checkpoint inhibitor treatment efficacy on contrast-enhanced computed tomography images of hepatocellular carcinomaYasuhiko Nakao, Takahito Nishihara, Ryu Sasaki, et al.
Medical Molecular Morphology|July 9, 2024
Liver fibrosis analysis using digital pathologyHisamitsu Miyaaki, Satoshi Miuma, Masanori Fukusima, et al.
World Journal of Gastrointestinal Oncology|January 29, 2026
Opportunities and challenges of artificial intelligence-assisted endoscopy and high-quality data for esophageal squamous cell carcinomaKen Kurisaki, Shinichiro Kobayashi, Taro Akashi, et al.
Diagnostics (Basel, Switzerland)|January 11, 2025
Benefits of Liver Volume and Serum Zinc Level Assessment for the Screening of Covert Hepatic Encephalopathy in Patients with Child-Pugh Class A CirrhosisMasanori Fukushima, Hisamitsu Miyaaki, Ryu Sasaki, et al.
Cancer Medicine|March 19, 2023
Peripheral lymphocyte fluctuation as an indicator of severe immune-related adverse events in patients treated with immune checkpoint inhibitorsMasafumi Haraguchi, Yasuhiko Nakao, Syouhei Narita, et al.
Clinical Journal of Gastroenterology|February 6, 2023
Evans' syndrome induced by atezolizumab plus bevacizumab combination therapy in advanced hepatocellular carcinomaMasanori Fukushima, Kazuaki Tajima, Ryu Sasaki, et al.
Pageof 3